{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:35:27Z","timestamp":1793079327123,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:00:00Z","timestamp":1769040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CHRU de Tours"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Up to 10% of small cell lung carcinomas do not express any neuroendocrine markers and are characterized by an expression of the transcription factor POU2F3. Recently, few cases of poorly differentiated carcinomas harboring POU2F3 expression have been described in the breast, cervix, and bladder. Herein, we report the morphological, immunohistochemical, and molecular characterization of two primary cutaneous POU2F3-expressing small cell carcinomas. The cases arose in the temple and on the occipital region in a 92-year-old woman and a 78-year-old man respectively. Microscopic examination revealed in both cases a large and ulcerated poorly differentiated neoplasm infiltrating the full thickness of the dermis with extension into the subcutaneous tissues in case #1. The tumors harbored solid and trabecular growth patterns and were composed of poorly differentiated highly mitotic cells. Immunohistochemical investigation revealed diffuse pancytokeratin positivity while no expression of cytokeratin 20, chromogranin A, synaptophysin, CD56, or INSM1 was detected. Diffuse nuclear expression of POU2F3 was observed. Transcriptomic analysis revealed a SBS7 mutation signature related to UV-induced DNA damages in one case and evidenced an expression profile similar to the one observed in POU2F3-expressing small cell lung cancers in both. Methylation analysis confirmed the proximity of the two cases with other skin cancers. To conclude, we report herein the first description of primary cutaneous small cell carcinoma POU2F3 subtype.<\/jats:p>","DOI":"10.1007\/s00428-026-04406-4","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:34:16Z","timestamp":1769045656000},"page":"1005-1011","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary cutaneous non neuroendocrine small cell carcinoma POU2F3 subtype: morphologic, immunohistochemical, transcriptomic and methylation analysis of two cases"],"prefix":"10.1007","volume":"489","author":[{"given":"Kerman","family":"Zyani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pissaloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charly","family":"Liddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahtab","family":"Samimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Tirode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas von","family":"Deimling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Guy\u00e9tant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Lantuejoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2201-6914","authenticated-orcid":false,"given":"Thibault","family":"Kervarrec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"4406_CR1","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41379-018-0110-y","volume":"31","author":"G Rindi","year":"2018","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B et al (2018) A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 31:1770\u20131786","journal-title":"Mod Pathol"},{"key":"4406_CR2","unstructured":"Busam KJ, Scolyer R, Tetzlaff MT, et al. Merkel cell carcinoma. In WHO Classification of Skin Tumours. IARC. Lyon."},{"key":"4406_CR3","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.21037\/tlcr-20-269","volume":"9","author":"S Lantuejoul","year":"2020","unstructured":"Lantuejoul S, Fernandez-Cuesta L, Damiola F et al (2020) New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts. Transl Lung Cancer Res 9:2233\u20132244","journal-title":"Transl Lung Cancer Res"},{"issue":"5","key":"4406_CR4","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.4049\/jimmunol.1801069","volume":"202","author":"H-A Ting","year":"2019","unstructured":"Ting H-A, von Moltke J (2019) The immune function of tuft cells at gut mucosal surfaces and beyond. J Immunol 202(5):1321\u20131329","journal-title":"J Immunol"},{"key":"4406_CR5","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41568-019-0133-9","volume":"19","author":"CM Rudin","year":"2019","unstructured":"Rudin CM, Poirier JT, Byers LA et al (2019) Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat Rev Cancer 19:289\u2013297","journal-title":"Nat Rev Cancer"},{"key":"4406_CR6","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/s41416-022-01957-6","volume":"127","author":"Y Yamada","year":"2022","unstructured":"Yamada Y, Bohnenberger H, Kriegsmann M et al (2022) Tuft cell-like carcinomas: novel cancer subsets present in multiple organs sharing a unique gene expression signature. Br J Cancer 127:1876\u20131885","journal-title":"Br J Cancer"},{"key":"4406_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/gcc.23026","volume":"61","author":"N Macagno","year":"2022","unstructured":"Macagno N, Pissaloux D, de la Fouchardi\u00e8re A et al (2022) Wholistic approach: transcriptomic analysis and beyond using archival material for molecular diagnosis. Genes Chromosomes Cancer 61:382\u2013393","journal-title":"Genes Chromosomes Cancer"},{"key":"4406_CR8","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469\u2013474","journal-title":"Nature"},{"key":"4406_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1002\/gcc.23041","volume":"61","author":"C Koelsche","year":"2022","unstructured":"Koelsche C, von Deimling A (2022) Methylation classifiers: Brain tumors, sarcomas, and what\u2019s next. Genes Chromosomes Cancer 61:346\u2013355","journal-title":"Genes Chromosomes Cancer"},{"key":"4406_CR10","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.ccell.2024.05.002","volume":"42","author":"Z Wang","year":"2024","unstructured":"Wang Z, Liu C, Zheng S et al (2024) Molecular subtypes of neuroendocrine carcinomas: a cross-tissue classification framework based on five transcriptional regulators. Cancer Cell 42:1106-1125.e8","journal-title":"Cancer Cell"},{"key":"4406_CR11","first-page":"1731","volume":"30","author":"D Huang","year":"2025","unstructured":"Huang D, Wang J, Chen L et al (2025) Molecular Subtypes and Targeted Therapeutic Strategies in Small Cell Lung Cancer: Advances, Challenges, and Future Perspectives. Mol Basel Switz 30:1731","journal-title":"Mol Basel Switz"},{"key":"4406_CR12","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ccell.2020.05.001","volume":"38","author":"AS Ireland","year":"2020","unstructured":"Ireland AS, Micinski AM, Kastner DW et al (2020) MYC drives temporal evolution of small cell lung cancer subtypes by reprogramming neuroendocrine fate. Cancer Cell 38:60-78.e12","journal-title":"Cancer Cell"},{"key":"4406_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.ccell.2024.01.010","volume":"42","author":"BY Nabet","year":"2024","unstructured":"Nabet BY, Hamidi H, Lee MC et al (2024) Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade. Cancer Cell 42:429-443.e4","journal-title":"Cancer Cell"},{"key":"4406_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.ccell.2020.12.014","volume":"39","author":"CM Gay","year":"2021","unstructured":"Gay CM, Stewart CA, Park EM et al (2021) Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities. Cancer Cell 39:346-360.e7","journal-title":"Cancer Cell"},{"key":"4406_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105062","volume":"102","author":"S Park","year":"2024","unstructured":"Park S, Hong TH, Hwang S et al (2024) Comprehensive analysis of transcription factor-based molecular subtypes and their correlation to clinical outcomes in small-cell lung cancer. EBioMedicine 102:105062","journal-title":"EBioMedicine"},{"key":"4406_CR16","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1101\/gad.314815.118","volume":"32","author":"Y-H Huang","year":"2018","unstructured":"Huang Y-H, Klingbeil O, He X-Y et al (2018) Pou2f3 is a master regulator of a tuft cell-like variant of small cell lung cancer. Genes Dev 32:915\u2013928","journal-title":"Genes Dev"},{"key":"4406_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0189340","volume":"12","author":"J Yamashita","year":"2017","unstructured":"Yamashita J, Ohmoto M, Yamaguchi T et al (2017) Skn-1a\/Pou2f3 functions as a master regulator to generate Trpm5-expressing chemosensory cells in mice. PLoS ONE 12:e0189340","journal-title":"PLoS ONE"},{"key":"4406_CR18","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nn.2820","volume":"14","author":"I Matsumoto","year":"2011","unstructured":"Matsumoto I, Ohmoto M, Narukawa M et al (2011) Skn-1a (Pou2f3) specifies taste receptor cell lineage. Nat Neurosci 14:685\u2013687","journal-title":"Nat Neurosci"},{"key":"4406_CR19","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature16527","volume":"529","author":"F Gerbe","year":"2016","unstructured":"Gerbe F, Sidot E, Smyth DJ et al (2016) Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites. Nature 529:226\u2013230","journal-title":"Nature"},{"key":"4406_CR20","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.jtho.2022.06.004","volume":"17","author":"MK Baine","year":"2022","unstructured":"Baine MK, Febres-Aldana CA, Chang JC et al (2022) POU2F3 in SCLC: clinicopathologic and genomic analysis with a focus on its diagnostic utility in neuroendocrine-low SCLC. J Thorac Oncol 17:1109\u20131121","journal-title":"J Thorac Oncol"},{"key":"4406_CR21","volume":"17","author":"S Mitsui","year":"2025","unstructured":"Mitsui S, Jimbo N, Tanaka Y et al (2025) Clinical Impact of POU2F3 Expression in Surgically Resected Pulmonary High-Grade Neuroendocrine Carcinoma. Cureus 17:e82758","journal-title":"Cureus"},{"key":"4406_CR22","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/PAS.0000000000002313","volume":"49","author":"M Kaczorowski","year":"2025","unstructured":"Kaczorowski M, Ylaya K, Ch\u0142opek M et al (2025) Expression of POU2F3 transcription factor and POU2AF2, POU2F3 coactivator, in tuft cell-like carcinoma and other tumors. Am J Surg Pathol 49:62\u201372","journal-title":"Am J Surg Pathol"},{"key":"4406_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41379-018-0155-y","volume":"32","author":"T Kervarrec","year":"2019","unstructured":"Kervarrec T, Tallet A, Miquelestorena-Standley E et al (2019) Diagnostic accuracy of a panel of immunohistochemical and molecular markers to distinguish Merkel cell carcinoma from other neuroendocrine carcinomas. Mod Pathol 32:499\u2013510","journal-title":"Mod Pathol"},{"key":"4406_CR24","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/ajcp\/aqaf046","volume":"164","author":"P Karpi\u0144ski","year":"2025","unstructured":"Karpi\u0144ski P, Wu C-L, Hoang MP (2025) NeuroD1 is frequently expressed in Merkel cell polyomavirus-negative and keratin 20-negative Merkel cell carcinoma: a potential diagnostic pitfall. Am J Clin Pathol 164:323\u2013330","journal-title":"Am J Clin Pathol"},{"key":"4406_CR25","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.neo.2018.10.003","volume":"20","author":"E Chteinberg","year":"2018","unstructured":"Chteinberg E, Sauer CM, Rennspiess D et al (2018) Neuroendocrine key regulator gene expression in Merkel cell carcinoma. Neoplasia 20:1227\u20131235","journal-title":"Neoplasia"},{"key":"4406_CR26","doi-asserted-by":"crossref","unstructured":"Karpinski P, Mendez-Pena JE, Wu C-L, et al. POU4F3 Is a Sensitive and Specific Marker of Merkel Cell Carcinoma. Mod. Pathol. Off. J. U. S. Can. Acad. Pathol. Inc 2025; 38; 100627.","DOI":"10.1016\/j.modpat.2024.100627"},{"key":"4406_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jid.2021.07.175","volume":"142","author":"T Kervarrec","year":"2022","unstructured":"Kervarrec T, Appenzeller S, Samimi M et al (2022) Merkel cell polyomavirus-negative Merkel cell carcinoma originating from in situ squamous cell carcinoma: a keratinocytic tumor with neuroendocrine differentiation. J Invest Dermatol 142:516\u2013527","journal-title":"J Invest Dermatol"},{"key":"4406_CR28","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1038\/s41379-022-01151-2","volume":"35","author":"RC DeCoste","year":"2022","unstructured":"DeCoste RC, Walsh NM, Gaston D et al (2022) RB1-deficient squamous cell carcinoma: the proposed source of combined Merkel cell carcinoma. Mod Pathol 35:1829\u20131836","journal-title":"Mod Pathol"},{"key":"4406_CR29","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/s41379-021-00928-1","volume":"35","author":"PW Harms","year":"2022","unstructured":"Harms PW, Verhaegen ME, Hu K et al (2022) Genomic evidence suggests that cutaneous neuroendocrine carcinomas can arise from squamous dysplastic precursors. Mod Pathol 35:506\u2013514","journal-title":"Mod Pathol"},{"key":"4406_CR30","unstructured":"Liv T, Touz\u00e9 A, Schrama D, et al. RB1 inactivation in cutaneous carcinomas. Histopathology December 2025."},{"key":"4406_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-020-00727-4","volume":"12","author":"GJ Starrett","year":"2020","unstructured":"Starrett GJ, Thakuria M, Chen T et al (2020) Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma. Genome Med 12:30","journal-title":"Genome Med"},{"key":"4406_CR32","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/j.1365-2133.2009.09351.x","volume":"161","author":"A Toll","year":"2009","unstructured":"Toll A, Salgado R, Y\u00e9benes M et al (2009) Myc gene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma. Br J Dermatol 161:1112\u20131118","journal-title":"Br J Dermatol"},{"key":"4406_CR33","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1038\/jid.2008.365","volume":"129","author":"KG Paulson","year":"2009","unstructured":"Paulson KG, Lemos BD, Feng B et al (2009) Array-CGH reveals recurrent genomic changes in Merkel cell carcinoma including amplification of L-Myc. J Invest Dermatol 129:1547\u20131555","journal-title":"J Invest Dermatol"},{"key":"4406_CR34","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abc2578","volume":"7","author":"AS Patel","year":"2021","unstructured":"Patel AS, Yoo S, Kong R et al (2021) Prototypical oncogene family Myc defines unappreciated distinct lineage states of small cell lung cancer. Sci Adv 7:eabc2578","journal-title":"Sci Adv"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04406-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04406-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-026-04406-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:24:52Z","timestamp":1793078692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-026-04406-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,22]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["4406"],"URL":"https:\/\/doi.org\/10.1007\/s00428-026-04406-4","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,22]]},"assertion":[{"value":"9 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The local Ethics Committee in Human Research of Tours (France) approved the study (no. ID RCB2009-A01056-51).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}